CoChat
Sign Up
Cited by 106

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

PDZ domains: the building blocks regulating tumorigenesis

Subbaiah, Vanitha Krishna, Kranjec, Christian, Thomas, Miranda, Banks, Lawrence·2011·Biochemical Journal
DOI 10.1042/bj20110903
Open this paper in CoChat — free account

Abstract

Over 250 PDZ (PSD95/Dlg/ZO-1) domain-containing proteins have been described in the human proteome. As many of these possess multiple PDZ domains, the potential combinations of associations with proteins that possess PBMs (PDZ-binding motifs) are vast. However, PDZ domain recognition is a highly specific process, and much less promiscuous than originally thought. Furthermore, a large number of PDZ domain-containing proteins have been linked directly to the control of processes whose loss, or inappropriate activation, contribute to the development of human malignancies. These regulate processes as diverse as cytoskeletal organization, cell polarity, cell proliferation and many signal transduction pathways. In the present review, we discuss how PBM–PDZ recognition and imbalances therein can perturb cellular homoeostasis and ultimately contribute to malignant progression.

Overview

Integrity signals

Registry

Crossref · 10.1042/bj20110903

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Research works printed but not linked: 117

  1. Ponting, 1997, PDZ domains: targeting signalling molecules to sub-membranous sites, BioEssays, 19, 469, 10.1002/bies.950190606 · DOI
  2. Ponting, 1997, Evidence for PDZ domains in bacteria, yeast, and plants, Protein Sci., 6, 464, 10.1002/pro.5560060225 · DOI
  3. Thomas, 2008, Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates, Virology, 376, 371, 10.1016/j.virol.2008.03.021 · DOI
  4. Doyle, 1996, Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ, Cell, 85, 1067, 10.1016/S0092-8674(00)81307-0 · DOI
  5. Morais Cabral, 1996, Crystal structure of a PDZ domain, Nature, 382, 649, 10.1038/382649a0 · DOI
  6. Zhang, 2007, Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein, J. Virol., 81, 3618, 10.1128/JVI.02044-06 · DOI
  7. Tochio, 2000, Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95, J. Mol. Biol., 295, 225, 10.1006/jmbi.1999.3350 · DOI
  8. Feng, 2003, Tandem PDZ repeats in glutamate receptor-interacting proteins have a novel mode of PDZ domain-mediated target binding, Nat. Struct. Biol., 10, 972, 10.1038/nsb992 · DOI
  9. Long, 2003, Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95, J. Mol. Biol., 327, 203, 10.1016/S0022-2836(03)00113-X · DOI
  10. Lue, 1996, Two independent domains of hDlg are sufficient for subcellular targeting: the PDZ1-2 conformational unit and an alternatively spliced domain, J. Cell Biol., 135, 1125, 10.1083/jcb.135.4.1125 · DOI
  11. Im, 2003, Crystal structure of the Shank PDZ–ligand complex reveals a class I PDZ interaction and a novel PDZ–PDZ dimerization, J. Biol. Chem., 278, 48099, 10.1074/jbc.M306919200 · DOI
  12. Utepbergenov, 2006, Dimerization of the scaffolding protein ZO-1 through the second PDZ domain, J. Biol. Chem., 281, 24671, 10.1074/jbc.M512820200 · DOI
  13. Wu, 2007, Domain-swapped dimerization of the second PDZ domain of ZO2 may provide a structural basis for the polymerization of claudins, J. Biol. Chem., 282, 35988, 10.1074/jbc.M703826200 · DOI
  14. Chen, 2008, Domain-swapped dimerization of ZO-1 PDZ2 generates specific and regulatory connexin43-binding sites, EMBO J., 27, 2113, 10.1038/emboj.2008.138 · DOI
  15. Saras, 1996, PDZ domains bind carboxy-terminal sequences of target proteins, Trends Biochem. Sci., 21, 455, 10.1016/S0968-0004(96)30044-3 · DOI
  16. Cowburn, 1997, Peptide recognition by PTB and PDZ domains, Curr. Opin. Struct. Biol., 7, 835, 10.1016/S0959-440X(97)80155-8 · DOI
  17. Wheeler, 2011, Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling, Oncogene, 30, 32, 10.1038/onc.2010.389 · DOI
  18. Zhang, 2006, Convergent and divergent ligand specificity among PDZ domains of the LAP and zonula occludens (ZO) families, J. Biol. Chem., 281, 22299, 10.1074/jbc.M602902200 · DOI
  19. Cohen, 1996, Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation, Neuron, 17, 759, 10.1016/S0896-6273(00)80207-X · DOI
  20. Kühne, 2000, Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6, Oncogene, 19, 5884, 10.1038/sj.onc.1203988 · DOI
  21. Adey, 2000, Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding, Cancer Res., 60, 35
  22. von Nandelstadh, 2009, A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies, Mol. Cell. Biol., 29, 822, 10.1128/MCB.01454-08 · DOI
  23. Gardoni, 2003, CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction, J. Biol. Chem., 278, 44745, 10.1074/jbc.M303576200 · DOI
  24. Radziwill, 2003, The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain, Mol. Cell. Biol., 23, 4663, 10.1128/MCB.23.13.4663-4672.2003 · DOI
  25. Lee, 1997, Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U.S.A., 94, 6670, 10.1073/pnas.94.13.6670 · DOI · Paper page
  26. Javier, 2008, Cell polarity proteins: common targets for tumorigenic human viruses, Oncogene, 27, 7031, 10.1038/onc.2008.352 · DOI · Paper page
  27. Frese, 2006, Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor, EMBO J., 25, 1406, 10.1038/sj.emboj.7601030 · DOI
  28. Kiyono, 1997, Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U.S.A., 94, 11612, 10.1073/pnas.94.21.11612 · DOI · Paper page
  29. Thomas, 2008, Human papillomaviruses, cervical cancer and cell polarity, Oncogene, 27, 7018, 10.1038/onc.2008.351 · DOI · Paper page
  30. Butz, 2003, siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells, Oncogene, 22, 5938, 10.1038/sj.onc.1206894 · DOI · Paper page
  31. Higuchi, 2007, Cooperation of NF-κB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line, J. Virol., 81, 11900, 10.1128/JVI.00532-07 · DOI
  32. Thomas, 2005, The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins, Oncogene, 24, 6222, 10.1038/sj.onc.1208757 · DOI · Paper page
  33. Humbert, 2008, Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module, Oncogene, 27, 6888, 10.1038/onc.2008.341 · DOI
  34. Dow, 2008, Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling, Oncogene, 27, 5988, 10.1038/onc.2008.219 · DOI · Paper page
  35. Gardiol, 2006, Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression, Int. J. Cancer, 119, 1285, 10.1002/ijc.21982 · DOI
  36. Vaira, 2011, Aberrant overexpression of the cell polarity module Scribble in human cancer, Am. J. Pathol., 178, 2478, 10.1016/j.ajpath.2011.02.028 · DOI
  37. Glaunsinger, 2000, Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins, Oncogene, 19, 5270, 10.1038/sj.onc.1203906 · DOI · Paper page
  38. Kranjec, 2011, A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions, J. Virol., 85, 1757, 10.1128/JVI.01756-10 · DOI
  39. Tomaić, 2009, Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators, Oncogene, 28, 1, 10.1038/onc.2008.365 · DOI
  40. Aranda, 2008, Par complex in cancer: a regulator of normal cell polarity joins the dark side, Oncogene, 27, 6878, 10.1038/onc.2008.340 · DOI
  41. Thiery, 2002, Epithelial–mesenchymal transitions in tumour progression, Nat. Rev. Cancer, 2, 442, 10.1038/nrc822 · DOI
  42. Wong, 2003, Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled, Mol. Cell, 12, 1251, 10.1016/S1097-2765(03)00427-1 · DOI
  43. Gao, 2010, Dishevelled: the hub of Wnt signaling, Cell. Signalling, 22, 717, 10.1016/j.cellsig.2009.11.021 · DOI
  44. Clevers, 2006, Wnt/β-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018 · DOI · Paper page
  45. Veeman, 2003, A second canon: functions and mechanisms of β-catenin-independent Wnt signaling, Dev. Cell, 5, 367, 10.1016/S1534-5807(03)00266-1 · DOI · Paper page
  46. Habas, 2001, Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1, Cell, 107, 843, 10.1016/S0092-8674(01)00614-6 · DOI · Paper page
  47. Liu, 2008, Mechanism of activation of the Formin protein Daam1, Proc. Natl. Acad. Sci. U.S.A., 105, 210, 10.1073/pnas.0707277105 · DOI
  48. Weeraratna, 2002, Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma, Cancer Cell, 1, 279, 10.1016/S1535-6108(02)00045-4 · DOI
  49. Uematsu, 2003, Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of β-catenin, Cancer Res., 63, 4547
  50. Nagahata, 2003, Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers, Cancer Sci., 94, 515, 10.1111/j.1349-7006.2003.tb01475.x · DOI
  51. Shan, 2005, Identification of a specific inhibitor of the dishevelled PDZ domain, Biochemistry, 44, 15495, 10.1021/bi0512602 · DOI
  52. Grandy, 2009, Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled, J. Biol. Chem., 284, 16256, 10.1074/jbc.M109.009647 · DOI
  53. Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1 · DOI · Paper page
  54. Giles, 2003, Caught up in a Wnt storm: Wnt signaling in cancer, Biochim. Biophys. Acta, 1653, 1
  55. Matsumine, 1996, Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein, Science, 272, 1020, 10.1126/science.272.5264.1020 · DOI
  56. Etienne-Manneville, 2005, Cdc42 and Par6-PKCζ regulate the spatially localized association of Dlg1 and APC to control cell polarization, J. Cell Biol., 170, 895, 10.1083/jcb.200412172 · DOI
  57. Erdmann, 2000, The adenomatous polyposis coli protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain, Oncogene, 19, 3894, 10.1038/sj.onc.1203725 · DOI
  58. Welters, 2008, The protein tyrosine phosphatase-BL, modulates pancreatic β-cell proliferation by interaction with the Wnt signalling pathway, J. Endocrinol., 197, 543, 10.1677/JOE-07-0262 · DOI
  59. Pedemonte, 1998, Novel germline APC variants in patients with multiple adenomas, Genes Chromosomes Cancer, 22, 257, 10.1002/(SICI)1098-2264(199808)22:4<257::AID-GCC1>3.0.CO;2-U · DOI
  60. Miyoshi, 1992, Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients, Proc. Natl. Acad. Sci. U.S.A., 89, 4452, 10.1073/pnas.89.10.4452 · DOI
  61. Salmena, 2008, Tenets of PTEN tumor suppression, Cell, 133, 403, 10.1016/j.cell.2008.04.013 · DOI
  62. Chen, 2005, Par-3 controls tight junction assembly through the Rac exchange factor Tiam1, Nat. Cell Biol., 7, 262, 10.1038/ncb1226 · DOI
  63. Ozdamar, 2005, Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity, Science, 307, 1603, 10.1126/science.1105718 · DOI · Paper page
  64. Valiente, 2005, Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases, J. Biol. Chem., 280, 28936, 10.1074/jbc.M504761200 · DOI
  65. Dobrosotskaya, 2000, MAGI-1 interacts with β-catenin and is associated with cell–cell adhesion structures, Biochem. Biophys. Res. Commun., 270, 903, 10.1006/bbrc.2000.2471 · DOI
  66. Kotelevets, 2005, Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness, FASEB J., 19, 115, 10.1096/fj.04-1942fje · DOI
  67. Leslie, 2002, PTEN: the down side of PI 3-kinase signalling, Cell. Signalling, 14, 285, 10.1016/S0898-6568(01)00234-0 · DOI · Paper page
  68. Deichmann, 2002, PTEN/MMAC1 expression in melanoma resection specimens, Br. J. Cancer, 87, 1431, 10.1038/sj.bjc.6600653 · DOI
  69. Hayashi, 2010, NHERF1/EBP50 is a new marker in colorectal cancer, Neoplasia, 12, 1013, 10.1593/neo.10780 · DOI
  70. Dai, 2004, NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer, Oncogene, 23, 8681, 10.1038/sj.onc.1207962 · DOI
  71. Takahashi, 2006, PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling, EMBO J., 25, 910, 10.1038/sj.emboj.7600979 · DOI
  72. Accardi, 2011, E6 and e7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1, J. Virol., 85, 8208, 10.1128/JVI.00114-11 · DOI
  73. Wang, 2004, Mutational analysis of the tyrosine phosphatome in colorectal cancers, Science, 304, 1164, 10.1126/science.1096096 · DOI
  74. Hou, 2010, PTPH1 dephosphorylates and cooperates with p38γ MAPK to increase ras oncogenesis through PDZ-mediated interaction, Cancer Res., 70, 2901, 10.1158/0008-5472.CAN-09-3229 · DOI
  75. Han, 2007, The pathways to tumor suppression via route p38, Trends Biochem. Sci., 32, 364, 10.1016/j.tibs.2007.06.007 · DOI
  76. Zhi, 2011, PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization, Oncogene, 30, 1706, 10.1038/onc.2010.543 · DOI
  77. Jing, 2007, Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins, J. Virol., 81, 2231, 10.1128/JVI.01979-06 · DOI
  78. Saras, 1997, Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas, J. Biol. Chem., 272, 20979, 10.1074/jbc.272.34.20979 · DOI
  79. Ungefroren, 2001, FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis, J. Cell Sci., 114, 2735, 10.1242/jcs.114.15.2735 · DOI
  80. Abaan, 2005, PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's sarcoma tumorigenesis, Oncogene, 24, 2715, 10.1038/sj.onc.1208247 · DOI
  81. Zhang, 2009, Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle, J. Cell Biol., 184, 785, 10.1083/jcb.200810155 · DOI
  82. Glondu-Lassis, 2010, PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase, Cancer Res., 70, 5116, 10.1158/0008-5472.CAN-09-4368 · DOI
  83. Cuppen, 2000, The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL, Eur. J. Cell Biol., 79, 283, 10.1078/S0171-9335(04)70031-X · DOI
  84. Lai, 2007, PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration, J. Biol. Chem., 282, 24381, 10.1074/jbc.M701499200 · DOI
  85. Révillion, 2009, Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer, Int. J. Cancer, 124, 638, 10.1002/ijc.23989 · DOI
  86. Yeh, 2006, Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma, Clin. Cancer Res., 12, 1097, 10.1158/1078-0432.CCR-05-1383 · DOI
  87. Ying, 2006, Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter, Leukemia, 20, 1173, 10.1038/sj.leu.2404193 · DOI
  88. Spanos, 2008, The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth, J. Virol., 82, 2493, 10.1128/JVI.02188-07 · DOI
  89. Radziwill, 2007, Regulation of c-Src by binding to the PDZ domain of AF-6, EMBO J., 26, 2633, 10.1038/sj.emboj.7601706 · DOI
  90. Weiss, 2007, c-Src is a PDZ interaction partner and substrate of the E3 ubiquitin ligase Ligand-of-Numb protein X1, FEBS Lett., 581, 5131, 10.1016/j.febslet.2007.09.062 · DOI
  91. Baumgartner, 2008, c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site, Mol. Cell. Biol., 28, 642, 10.1128/MCB.01024-07 · DOI · Paper page
  92. DeMali, 2003, Coupling membrane protrusion and cell adhesion, J. Cell Sci., 116, 2389, 10.1242/jcs.00605 · DOI
  93. Nobes, 1999, Rho GTPases control polarity, protrusion, and adhesion during cell movement, J. Cell Biol., 144, 1235, 10.1083/jcb.144.6.1235 · DOI
  94. García-Mata, 2007, Catching a GEF by its tail, Trends Cell Biol., 17, 36, 10.1016/j.tcb.2006.11.004 · DOI
  95. Advani, 2002, Bcr-Abl variants: biological and clinical aspects, Leuk. Res., 26, 713, 10.1016/S0145-2126(01)00197-7 · DOI
  96. Boguski, 1993, Proteins regulating Ras and its relatives, Nature, 366, 643, 10.1038/366643a0 · DOI
  97. Kourlas, 2000, Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia, Proc. Natl. Acad. Sci. U.S.A., 97, 2145, 10.1073/pnas.040569197 · DOI
  98. Taya, 2001, Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF, J. Cell Biol., 155, 809, 10.1083/jcb.200106139 · DOI
  99. Bourguignon, 2006, Hyaluronan–CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase Cϵ–Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells, J. Biol. Chem., 281, 14026, 10.1074/jbc.M507734200 · DOI
  100. Rujkijyanont, 2007, Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman–Diamond syndrome, Br. J. Haematol., 137, 537, 10.1111/j.1365-2141.2007.06608.x · DOI
  101. Ong, 2009, LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer, Oncogene, 28, 4189, 10.1038/onc.2009.266 · DOI
  102. Montero, 2011, P-Rex1 participates in neuregulin–ErbB signal transduction and its expression correlates with patient outcome in breast cancer, Oncogene, 30, 1059, 10.1038/onc.2010.489 · DOI
  103. Sosa, 2010, Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer, Mol. Cell, 40, 877, 10.1016/j.molcel.2010.11.029 · DOI
  104. Qin, 2009, Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis, Oncogene, 28, 1853, 10.1038/onc.2009.30 · DOI
  105. Ledezma-Sánchez, 2010, Sphingosine-1-phosphate receptor S1P1 is regulated by direct interactions with P-Rex1, a Rac guanine nucleotide exchange factor, Biochem. Biophys. Res. Commun., 391, 1647, 10.1016/j.bbrc.2009.12.108 · DOI
  106. Chen, 2011, CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease, Int. J. Cancer, 128, 266, 10.1002/ijc.25356 · DOI
  107. Takahashi, 2011, Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer, Breast Cancer
  108. Masuda, 2005, Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis, J. Biol. Chem., 280, 42164, 10.1074/jbc.M507136200 · DOI
  109. Masuda, 2010, CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells, J. Biol. Chem., 285, 15511, 10.1074/jbc.M109.076653 · DOI
  110. García-Mata, 2007, The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity, Mol. Cell. Biol., 27, 8683, 10.1128/MCB.00157-07 · DOI
  111. Muders, 2006, Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma, Cancer Res., 66, 10264, 10.1158/0008-5472.CAN-06-2321 · DOI
  112. Favre-Bonvin, 2005, Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor β signaling and triggers its degradation by the proteasome, J. Virol., 79, 4229, 10.1128/JVI.79.7.4229-4237.2005 · DOI
  113. Muders, 2009, Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth, Clin. Cancer Res., 15, 4095, 10.1158/1078-0432.CCR-08-2837 · DOI
  114. Ligensa, 2001, A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor, J. Biol. Chem., 276, 33419, 10.1074/jbc.M104509200 · DOI
  115. Wu, 2009, Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC, Oncogene, 28, 2219, 10.1038/onc.2009.96 · DOI
  116. te Velthuis, 2011, Genome-wide analysis of PDZ domain binding reveals inherent functional overlap within the PDZ interaction network, PLoS ONE, 6, e16047, 10.1371/journal.pone.0016047 · DOI
  117. Junqueira, 2003, Random mutagenesis of PDZOmi domain and selection of mutants that specifically bind the Myc proto-oncogene and induce apoptosis, Oncogene, 22, 2772, 10.1038/sj.onc.1206359 · DOI

Cited by

See all 106

Metadata

Authors
Subbaiah, V. K., Kranjec, C., Thomas, M., & Banks, L.
Affiliations
International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I-34012 Trieste, Italy
Venue
Biochemical Journal
Publisher
Portland Press Ltd.
Published
2011-09-28
Volume
439
Issue
2
Pages
195-205
ISSN
  • 0264-6021
  • 1470-8728
DOI
10.1042/bj20110903
Cited by
106
References
13
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PDZ domains: the building blocks regulating tumorigenesis. https://app.cochat.ai/papers/10.1042/bj20110903
The paper
Subbaiah, V. K., Kranjec, C., Thomas, M., & Banks, L. (2011). PDZ domains: the building blocks regulating tumorigenesis. Biochemical Journal. https://doi.org/10.1042/bj20110903